The DOI matches its Crossref record; 86 of the 91 references it cites were found in a registry or an index.
The neurobiological basis of ADHD
Open accessAbstract
Attention-Deficit/Hyperactivity Disorder is not a single pathophysiological entity and appears to have a complex etiology. There are multiple genetic and environmental risk factors with small individual effect that act in concert to create a spectrum of neurobiological liability. Structural imaging studies show that brains of children with Attention-Deficit/Hyperactivity Disorder are significantly smaller than unaffected controls. The prefrontal cortex, basal ganglia and cerebellum are differentially affected and evidence indicating reduced connectivity in white matter tracts in key brain areas is emerging. Genetic, pharmacological, imaging, and animal models highlight the important role of dopamine dysregulation in the neurobiology of Attention-Deficit/Hyperactivity Disorder. To date, stimulants are the most effective psychopharmacological treatments available for Attention-Deficit/Hyperactivity Disorder. Currently only immediate release methylphenidate and atomoxetine are approved for the treatment of ADHD in Italy. Drug treatment should always be part of a comprehensive plan that includes psychosocial, behavioural and educational advice and interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reduced maternal thyroid capacity, poor maternal wellness, maternal age, post-maturity of the foetus, long working hours, maternal stress, foetal stress, prenatal exposure to alcohol and tobacco, and antepartum haemorrhage are prenatal factors that could influence ADHD development [54, 58, 65].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“highlighting prenatal, perinatal and postnatal difficulties, psychological adversities, exposure to chemical contaminants, or iron deficiency as factors that increase the probability of developing ADHD [54]”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The ADHD aetiology is complex with a multiple pathophysiological entity involving multiple genetic and environmental factors, acting together, and creating a spectrum of neurobiological responsibility [54]”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [54]
The cited source says what the claim attributes to it.
In the citing paper
“Genetics has a great weight in ADHD, with a heritability ranging from 60% to 90% according to several studies carried out in twins [54, 56].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [54]
The cited source says what the claim attributes to it.
In the citing paper
“Dysregulation of the dopaminergic system is related to the ADHD symptoms and signs [54].”
From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation
Shaw, P., Eckstrand, K., Sharp, W., Blumenthal, J., Lerch, J. P., Greenstein, D., Clasen, L., Evans, A., Giedd, J., & Rapoport, J. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707741104 · Cited by 1,819
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Attention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Genetics of attention deficit hyperactivity disorder
Faraone, S. V., & Larsson, H. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0070-0 · Cited by 1,338
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182
Characterizing cognition in ADHD: beyond executive dysfunction
Castellanos, F. X., Sonuga-Barke, E. J. S., Milham, M. P., & Tannock, R. (2006) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2006.01.011 · Cited by 1,170
SWANSON, J. M., KRAEMER, H. C., HINSHAW, S. P., ARNOLD, L. E., CONNERS, C. K., ABIKOFF, H. B., CLEVENGER, W., DAVIES, M., ELLIOTT, G. R., GREENHILL, L. L., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00011 · Cited by 1,157
Candidate gene studies of ADHD: a meta-analytic review
Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020
Sonuga-Barke, E. J. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.09.008 · Cited by 962
Academic and Educational Outcomes of Children With ADHD
Loe, I. M., & Feldman, H. M. (2007) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsl054 · Cited by 951
Shaw, P., Lerch, J., Greenstein, D., Sharp, W., Clasen, L., Evans, A., Giedd, J., Castellanos, F. X., & Rapoport, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.5.540 · Cited by 703
European clinical guidelines for hyperkinetic disorder ? first upgrade
Taylor, E., D�pfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Rothenberger, A., Sonuga-Barke, E., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1002-x · Cited by 682
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
Wang, M., Ramos, B. P., Paspalas, C. D., Shu, Y., Simen, A., Duque, A., Vijayraghavan, S., Brennan, A., Dudley, A., Nou, E., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.015 · Cited by 672
Attention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 653
NIGG, J. T., & CASEY, B. J. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050376 · Cited by 593
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Barkley, R. A. (1997) · Psychological Bulletin · doi:10.1037//0033-2909.121.1.65 · Cited by 580
Williams, N. M., Zaharieva, I., Martin, A., Langley, K., Mantripragada, K., Fossdal, R., Stefansson, H., Stefansson, K., Magnusson, P., Gudmundsson, O. O., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61109-9 · Cited by 572
Krain, A. L., & Castellanos, F. X. (2006) · Clinical Psychology Review · doi:10.1016/j.cpr.2006.01.005 · Cited by 495
Elkins, I. J., McGue, M., & Iacono, W. G. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1145 · Cited by 480
Cooper, J. E. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.179.1.85-a · Cited by 425
Milberger, S., Biederman, J., Faraone, S. V., Chen, L., & Jones, J. T. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.9.1138 · Cited by 414
Molecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“Candidate gene studies of ADHD have produced substantial evidence implicating several genes in the etiology of the disorder, with meta-analyses supportive of a role of the genes coding for DRD4, DRD5, SLC6A3, SNAP-25, and HTR1B [ 20 ].”
Motor coordination and kinaesthesis in boys with attention deficit–hyperactivity disorder
Piek, J. P., Pitcher, T. M., & Hay, D. A. (1999) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162299000341 · Cited by 403
Sallee, F. R., Mcgough, J., Wigal, T., Donahue, J., Lyne, A., & Biederman, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318191769e · Cited by 391
The top and the bottom of ADHD: a neuropsychological perspective
Sergeant, J. A., Geurts, H., Huijbregts, S., Scheres, A., & Oosterlaan, J. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.004 · Cited by 372 · cited 2×
“Individuals with ADHD present difficulties in several domains of attentional and cognitive functions: problem solving, planning, orienting, alerting, cognitive flexibility, sustained attention, response inhibition, and working memory [7,11].”
BackgroundVolkow, N. D., Wang, G.-J., Fowler, J. S., & Ding, Y.-S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.006 · Cited by 368
Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317
Sallee, F. R., Lyne, A., Wigal, T., & McGough, J. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0080 · Cited by 306
Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype
Neuman, R. J., Lobos, E., Reich, W., Henderson, C. A., Sun, L.-W., & Todd, R. D. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.049 · Cited by 277
The neuropsychopharmacology of attention-deficit/hyperactivity disorder
Pliszka, S. R. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.026 · Cited by 276
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269 · cited 2×
“MPH treatment causes an increase in DA signalling through multiple actions, including blockade of the DA reuptake transporter, amplification of DA response duration, disinhibition of the dopamine D2 receptor and amplification of DA tone [60].”
BackgroundStiefel, G., & Besag, F. (2010) · Drug Safety · doi:10.2165/11536380-000000000-00000 · Cited by 256
Academic and Educational Outcomes of Children With ADHD
Loe, I. M., & Feldman, H. M. (2007) · Ambulatory Pediatrics · doi:10.1016/j.ambp.2006.05.005 · Cited by 252
Silk, T. J., Vance, A., Rinehart, N., Bradshaw, J. L., & Cunnington, R. (2009) · Human Brain Mapping · doi:10.1002/hbm.20703 · Cited by 243
Makris, N., Buka, S. L., Biederman, J., Papadimitriou, G. M., Hodge, S. M., Valera, E. M., Brown, A. B., Bush, G., Monuteaux, M. C., Caviness, V. S., et al. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm156 · Cited by 239
Swanson, C. J., Perry, K. W., Koch-Krueger, S., Katner, J., Svensson, K. A., & Bymaster, F. P. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.022 · Cited by 214
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201
Anomalies of motor development in hyperactive boys
Denckla, M. B., & Rudel, R. G. (1978) · Annals of Neurology · doi:10.1002/ana.410030308 · Cited by 201
Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185
Franke, B., Vasquez, A. A., Johansson, S., Hoogman, M., Romanos, J., Boreatti-Hümmer, A., Heine, M., Jacob, C. P., Lesch, K.-P., Casas, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.170 · Cited by 183
Attention and executive functions profile in drug naive ADHD subtypes
Pasini, A., Paloscia, C., Alessandrelli, R., Porfirio, M. C., & Curatolo, P. (2007) · Brain and Development · doi:10.1016/j.braindev.2006.11.010 · Cited by 182 · cited 1×
“Individuals with ADHD present difficulties in several domains of attentional and cognitive functions: problem solving, planning, orienting, alerting, cognitive flexibility, sustained attention, response inhibition, and working memory [7,11].”
BackgroundSelf-citationCoghill, D. R., Rhodes, S. M., & Matthews, K. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.030 · Cited by 170
Causal Inferences Regarding Prenatal Alcohol Exposure and Childhood Externalizing Problems
D’Onofrio, B. M., Van Hulle, C. A., Waldman, I. D., Rodgers, J. L., Rathouz, P. J., & Lahey, B. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1296 · Cited by 170
Maternal Smoking and Hyperactivity in 8-Year-Old Children
Kotimaa, A., Moilanen, I. K., Taanila, A. M., Ebeling, H. E., Smalley, S. L., McGough, J. J., Hartikainen, A., & Järvelin, M. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046866.56865.a2 · Cited by 161
Therapy for attention-deficit hyperactivity disorder
Vinson, D. C. (1994) · Archives of Family Medicine · doi:10.1001/archfami.3.5.445 · Cited by 160
Suskauer, S. J., Simmonds, D. J., Fotedar, S., Blankner, J. G., Pekar, J. J., Denckla, M. B., & Mostofsky, S. H. (2008) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2008.20032 · Cited by 155
Genetics of attention-deficit hyperactivity disorder (ADHD)
Sharp, S. I., McQuillin, A., & Gurling, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.011 · Cited by 151
Handwriting Performance in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Racine, M. M. B., Majnemer, A., Shevell, M. I., & Snider, L. (2008) · Journal of Child Neurology · doi:10.1177/0883073807309244 · Cited by 150
Interaction of dopamine transporter genotype with prenatal smoke exposure on ADHD symptoms
Becker, K., El-Faddagh, M., Schmidt, M. H., Esser, G., & Laucht, M. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.07.004 · Cited by 142
Coffin, J. M., Baroody, S., Schneider, K., & O'Neill, J. (2005) · Cortex · doi:10.1016/s0010-9452(08)70275-2 · Cited by 134
Ogdie, M. N., Fisher, S. E., Yang, M., Ishii, J., Francks, C., Loo, S. K., Cantor, R. M., McCracken, J. T., McGough, J. J., Smalley, S. L., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/424387 · Cited by 133
Brain Neuroplasticity in Healthy, Hyperactive and Psychotic Children: Insights from Neuroimaging
Rapoport, J. L., & Gogtay, N. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301553 · Cited by 132
Crosbie, J., Pérusse, D., Barr, C. L., & Schachar, R. J. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.05.002 · Cited by 128
Awudu, G. A. H., & Besag, F. (2014) · Drug Safety · doi:10.1007/s40264-014-0201-8 · Cited by 116
Émond, V., Joyal, C. C., & Poissant, H. (2008) · L Encéphale · doi:10.1016/j.encep.2008.01.005 · Cited by 113
Faraone, S. V. (2009) · PubMed · Cited by 107
New insights into attention-deficit/hyperactivity disorder using structural neuroimaging
Shaw, P., & Rabin, C. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0059-0 · Cited by 101
Potter, A., NEWHOUSE, P. A., & Bucci, D. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.09.015 · Cited by 101
Biederman, J., Quinn, D., Weiss, M., Markabi, S., Weidenman, M., Edson, K., Karlsson, G., Pohlmann, H., & Wigal, S. (2003) · Pediatric Drugs · doi:10.2165/00148581-200305120-00006 · Cited by 95
Konrad, K., Neufang, S., Fink, G. R., & Herpertz‐Dahlmann, B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318157cb3b · Cited by 91
Psychopharmacological Intervention I
Singh, N. N., Epstein, M. H., Luebke, J. F., & Singh, Y. N. (1990) · The Journal of Special Education · doi:10.1177/002246699002400303 · Cited by 89
Goos, L. M., Crosbie, J., Payne, S., & Schachar, R. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08040621 · Cited by 89
Dopamine transporter genotype influences the physiological response to medication in ADHD
Gilbert, D. L. (2006) · Brain · doi:10.1093/brain/awl147 · Cited by 85
Practitioner Review: Early adversity and developmental disorders
Taylor, E., & Rogers, J. W. (2005) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00402.x · Cited by 85
Essential fatty acids and attention‐deficit–hyperactivity disorder: a systematic review
Raz, R., & Gabis, L. V. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2009.03351.x · Cited by 81
The genetics of attention-deficit/hyperactivity disorder
Coghill, D., & Banaschewski, T. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.78 · Cited by 79
Iron deficiency in Indian children with attention deficit hyperactivity disorder
Juneja, M., Jain, R., Singh, V., & Mallika, V. (2010) · Indian Pediatrics · doi:10.1007/s13312-010-0160-9 · Cited by 76
Lo‐Castro, A., D’Agati, E., & Curatolo, P. (2010) · Brain and Development · doi:10.1016/j.braindev.2010.05.011 · Cited by 76
Self-citationDecreased Callosal Thickness in Attention-Deficit/Hyperactivity Disorder
Eileen Luders, A., Narr, K. L., Hamilton, L. S., Phillips, O. R., Thompson, P. M., Valle, J. S., Del’Homme, M., Strickland, T. L., McCracken, J. T., Toga, A. W., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.027 · Cited by 76
Overflow movements and white matter abnormalities in ADHD
D’Agati, E., Casarelli, L., Pitzianti, M. B., & Pasini, A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.013 · Cited by 69
Self-citationKratochvil, C. J., Milton, D. R., Vaughan, B. S., & Greenhill, L. L. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-25 · Cited by 64
Psychopharmacological Interventions
Biederman, J., & Spencer, T. J. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.12.001 · Cited by 62
Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice
Weiss, S., Tzavara, E. T., Davis, R. J., Nomikos, G. G., McIntosh, J. M., Giros, B., & Martres, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.002 · Cited by 44
Pathophysiology of NSS in ADHD
Pasini, A., & D’Agati, E. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902789148 · Cited by 39
Self-citationMolecular Genetics of Attention-Deficit Hyperactivity Disorder
Retz, W., & Freitag, C. M. (2009) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000258449 · Cited by 35
Mechanism of Action of Stimulants in Attention-Deficit/Hyperactivity Disorder
Stahl, S. M. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09bs05890pur · Cited by 34
Hoeppner, J., Wandschneider, R., Neumeyer, M., Gierow, W., Haessler, F., Herpertz, S. C., & Buchmann, J. A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0008-1 · Cited by 26
The neurology of attention deficit/hyperactivity disorder
Curatolo, P. (2005) · Brain and Development · doi:10.1016/j.braindev.2005.02.003 · Cited by 21
Self-citationAttention Deficit Hyperactivity Disorder
Zhang, K., Davids, E., & Baldessarini, R. J. (2005) · Humana Press eBooks · doi:10.1385/1-59259-856-0:229 · Cited by 12
The neurology of Attention Deficit/Hyperactivity Disorder
D’Agati, E., Moavero, R., Paloscia, C., Pasini, A., & Curatolo, P. (2008) · Child Neurology · Cited by 3
Self-citationPharmacotherapy of Attention Deficit Hyperactivity Disorder
Xu, T. (2010) · Testowy IndexCopernicus · Cited by 3
Research works printed but not linked: 1
- Sen B Swaminathan S Maternal prenatal substance use and behavior problems among children in the U.S J Ment Health Policy Econ 2007 10 189 206 18166830
Cited by
Sorted by citations
The Roles of Serotonin in Neuropsychiatric Disorders
Pourhamzeh, M., Moravej, F. G., Arabi, M., Shahriari, E., Mehrabi, S., Ward, R. T., Ahadi, R., & Joghataei, M. T. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01064-9 · Cited by 409
Hyperactivity with Disrupted Attention by Activation of an Astrocyte Synaptogenic Cue
Nagai, J., Rajbhandari, A. K., Gangwani, M. R., Hachisuka, A., Coppola, G., Masmanidis, S. C., Fanselow, M. S., & Khakh, B. S. (2019) · Cell · doi:10.1016/j.cell.2019.03.019 · Cited by 328
Deshpande, G., Wang, P., Rangaprakash, D., & Wilamowski, B. (2015) · IEEE Transactions on Cybernetics · doi:10.1109/tcyb.2014.2379621 · Cited by 161
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147
Glutamatergic synapses in neurodevelopmental disorders
Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 146
Metadata
- Authors
- Curatolo, P., D'Agati, E., & Moavero, R.
- Affiliations
- University of Rome Tor Vergata (IT)
- Corresponding author
- Curatolo, Paolo
- Venue
- Italian Journal of Pediatrics
- Published
- 2010
- Volume
- 36
- Issue
- 1
- Pages
- 79
- ISSN
- 1720-8424 (ISSN-L)
- 1824-7288
- PMC
- PMC3016271
- OpenAlex
- W2163811629
- Cited by
- 189
- References
- 91
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 18 · 2023: 9 · 2022: 16 · 2021: 14 · 2020: 13 · 2019: 18 · 2018: 11 · 2017: 6 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 15 · 2012: 9
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- The Italian Journal of Pediatrics/Italian journal of pediatrics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, ADHD pathophysiology, neurobiology of ADHD, genetic risk factors, environmental risk factors, structural brain abnormalities, prefrontal cortex, basal ganglia, cerebellum, white matter connectivity, dopamine dysregulation, stimulant pharmacotherapy, methylphenidate, atomoxetine, psychosocial interventions
- MeSH terms
- Atomoxetine Hydrochloride, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Basal Ganglia, Behavior Therapy, Brain, Cerebellum, Dopamine, Drug Therapy, Combination, Humans, Italy, Methylphenidate, Propylamines, Risk Factors, Dopamine Agents, Treatment Outcome, Prefrontal Cortex, Dopamine Uptake Inhibitors, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
